ESTEVE CDMO's Strategic Acquisition of Regis Technologies to Strengthen U.S. Operations ESTEVE CDMO has acquired Regis Technologies, enhancing its capabilities in the U.S. for contract development and manufacturing of pharmaceutical ingredients.

ESTEVE CDMO's Strategic Acquisition of Regis Technologies to Strengthen U.S. Operations #USA #Chicago #pharmaceutical #ESTEVE #Regis_Technologies

ESTEVE Expands US Presence by Acquiring Regis Technologies, Enhancing CDMO Offerings ESTEVE's acquisition of Regis Technologies allows the company to enhance its CDMO capabilities in the US, streamlining drug development processes.

ESTEVE Expands US Presence by Acquiring Regis Technologies, Enhancing CDMO Offerings #USA #Chicago #CDMO #ESTEVE #Regis_Technologies

ESTEVE Expands Its US Footprint by Acquiring Regis Technologies to Enhance Service Offerings ESTEVE's recent acquisition of Regis Technologies marks a significant expansion of its service offerings in the United States. This strategic move reinforces ESTEVE's commitment to enhancing pharmaceutical development.

ESTEVE Expands Its US Footprint by Acquiring Regis Technologies to Enhance Service Offerings #USA #Chicago #CDMO #ESTEVE #Regis_Technologies

ESTEVE Expands its US Presence by Acquiring Regis Technologies as a Strategic Move This acquisition allows ESTEVE to enhance its contract development services for pharmaceutical ingredients in the U.S., marking a significant expansion.

ESTEVE Expands its US Presence by Acquiring Regis Technologies as a Strategic Move #USA #Chicago #CDMO #ESTEVE #Regis_Technologies

ESTEVE's Strategic Acquisition of Regis Technologies Boosts US Pharmaceutical Manufacturing Capabilities ESTEVE enhances its presence in the US market by acquiring Regis Technologies, expanding its contract development and manufacturing services for drug production.

ESTEVE's Strategic Acquisition of Regis Technologies Boosts US Pharmaceutical Manufacturing Capabilities #USA #Chicago #CDMO #ESTEVE #Regis_Technologies